are E-Cigarette Flavors associated with Exposure to Nicotine and Toxicants? Findings from Wave 2 of the Population assessment of Tobacco and health (PaTh) Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Smith (2019)
Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Smith (2020)
The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Smith (2020)
Intention to quit Vaping among United States adolescents.
Population Clinical
Cessation
Tobacco
Smith (2021)
Metabolome-wide association study of flavorant vanillin exposure in bronchial epithelial cells reveals disease-related perturbations in metabolism.
Nonclinical
Immunotoxicity
In Vivo
Smith (2021)
associations Between Nicotine Knowledge and Smoking Cessation Behaviors among US adults Who Smoke.
Population Clinical
Cessation
Tobacco
Snell (2022)
Short-term exposure of female BaLB/cJ mice to e-cigarette aerosol promotes neutrophil recruitment and enhances neutrophil-platelet aggregation in pulmonary microvasculature.
Nonclinical
Safety Effects In Animals
Acute Exposure
Snoderly (2023)
Main and Interactive Effects of Nicotine Product Type on Sleep health among Dual Combustible and E-Cigarette Users.
Individual Clinical
Safety
Adverse Effects
So (2021)
Nicotine absorption from e-cigarettes over 12 months.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Soar (2019)
quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users.
Population Clinical
Cessation
ENDS
Sobieski (2022)